S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

HOTH Hoth Therapeutics Inc

1.21

-0.019 (-1.55%)

After Hours

Last Updated: 16:27:46

Delayed by 15 minutes

Hoth Therapeutics completes site recruitment for atopic dermatitis study cohort 1

To read the full story on Seeking Alpha, click here.

Hoth Therapeutics (NASDAQ:HOTH)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Hoth Therapeutics Charts.

Hoth Therapeutics (NASDAQ:HOTH)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Hoth Therapeutics Charts.

Hoth Therapeutics Inc News

Hoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024
Wednesday 1 May 2024 (3 days ago) • PR Newswire (US)

Hoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross Proceeds
Wednesday 27 March 2024 (1 month ago) • PR Newswire (US)

Hoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatment
Wednesday 27 March 2024 (1 month ago) • PR Newswire (US)

Hoth Therapeutics Announces Positive Data In Completed Study of Alzheimer's Disease Pre-Clinical Treatment with HT-ALZ
Tuesday 19 March 2024 (1 month ago) • PR Newswire (US)

Hoth Therapeutics Retains Venable LLP to Expand Its Patent Portfolio
Thursday 29 February 2024 (2 months ago) • PR Newswire (US)

Hoth Therapeutics Engages Altasciences to Perform Key Study for HT-KIT Cancer Fighting Therapeutic
Monday 26 February 2024 (2 months ago) • PR Newswire (US)

Hoth Therapeutics to Attend BIO CEO and Investor Conference, February 26-27, 2024
Tuesday 13 February 2024 (3 months ago) • PR Newswire (US)

Hoth Therapeutics Announces it Received FDA Approval to Expand HT-001 Clinical Trial to Treat Severely Ill Patients
Thursday 18 January 2024 (3 months ago) • PR Newswire (US)

Form 8-K - Current report
Tuesday 9 January 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 8 January 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 8 January 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 8 January 2024 (4 months ago) • Edgar (US Regulatory)

More Hoth Therapeutics Inc News Articles

Marketing Worldwide (PK)

Bell Buckle (PK)

Yuenglings Ice Cream (PK)

Indoor Harvest (PK)

RespireRx Pharmaceuticals (PK)

Moon Equity (PK)

Ubiquitech Software (PK)

Umbra Applied Technologies (PK)

Brookmount Explorations (PK)

Astra Energy (QB)

Global Developments (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions